queenscarlet88
Bluelighter
Hi all,
Cannabidiol (CBD) is a nonpsychoactive cannabinoid, but it still exerts effects on the brain. I was hoping that somebody might be able to shed some light on what exactly those effects are. Specifically, I am trying to figure out whether CBD is in any way GABAergic.
The Wikipedia article on CBD provides what appears to be a pretty comprehensive overview of the research into CBD's pharmacology:
GABA isn't mentioned at all here. So why am I worried about it? As I have noted in a couple of other threads, I am a former benzodiazepine addict, so it is imperative that I avoid any GABAergics, especially GABA(A) agonists.
What's giving me pause is that CBD works as an anticonvulsant. According to this article, it enhances the anticonvulsant action of phenobarbitol, which is GABAergic. This worries me.
Interestingly, though, the linked article also says that it "reliably reduced the anticonvulsant potencies of chlordiazepoxide, clonazepam, trimethadione and ethosuximide" (emphasis mine). Chlordiazepoxide and clonazepam are, of course, both benzos. Considering my need to avoid GABAergics, it's a good sign that CBD reduces the activity of chlordiazepoxide and clonazepam, right?
Many thanks to anyone who can help me understand whether there's anything to worry about here.
Cannabidiol (CBD) is a nonpsychoactive cannabinoid, but it still exerts effects on the brain. I was hoping that somebody might be able to shed some light on what exactly those effects are. Specifically, I am trying to figure out whether CBD is in any way GABAergic.
The Wikipedia article on CBD provides what appears to be a pretty comprehensive overview of the research into CBD's pharmacology:
Cannabidiol has a very low affinity for CB1 and CB2 receptors but acts as an indirect antagonist of their agonists. While one would assume that this would cause cannabidiol to reduce the effects of THC, it may potentiate THC's effects by increasing CB1 receptor density or through another CB1-related mechanism. It is also an inverse agonist of CB2 receptors. Recently, it was found to be an antagonist at the putative new cannabinoid receptor, GPR55, a GPCR expressed in the caudate nucleus and putamen. Cannabidiol has also been shown to act as a 5-HT1A receptor agonist, an action which is involved in its antidepressant, anxiolytic, and neuroprotective] effects. Cannabidiol is an allosteric modulator of μ and δ-opioid receptors. Cannabidiol's pharmacologial effects have also been attributed to PPAR-γ receptor agonism and intracellular calcium release.
GABA isn't mentioned at all here. So why am I worried about it? As I have noted in a couple of other threads, I am a former benzodiazepine addict, so it is imperative that I avoid any GABAergics, especially GABA(A) agonists.
What's giving me pause is that CBD works as an anticonvulsant. According to this article, it enhances the anticonvulsant action of phenobarbitol, which is GABAergic. This worries me.
Interestingly, though, the linked article also says that it "reliably reduced the anticonvulsant potencies of chlordiazepoxide, clonazepam, trimethadione and ethosuximide" (emphasis mine). Chlordiazepoxide and clonazepam are, of course, both benzos. Considering my need to avoid GABAergics, it's a good sign that CBD reduces the activity of chlordiazepoxide and clonazepam, right?
Many thanks to anyone who can help me understand whether there's anything to worry about here.
